By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Emergent BioSolutions 

2273 Research Boulevard
Suite 400
Rockville  Maryland  20850  U.S.A.
Phone: 301-795-1800 Fax: 301-795-1899

Emergent BioSolutions Inc. is a biopharmaceutical company focused on the development, manufacture and commercialization of vaccines and therapeutics that assist the body’s immune system to prevent or treat disease. Emergent’s marketed product, BioThrax® (Anthrax Vaccine Adsorbed), is the only vaccine licensed by the U.S. Food and Drug Administration for the prevention of anthrax infection. Emergent’s development pipeline includes programs focused on anthrax, botulism, tuberculosis, typhoid, hepatitis B and chlamydia.

Key Statistics

Ownership: Public

Web Site: Emergent BioSolutions
Symbol: EBS

Company News
Emergent BioSolutions (EBS) To Participate In June 2014 Investor Conferences 5/29/2014 7:37:02 AM
Emergent BioSolutions (EBS) To Hold Annual Meeting Of Stockholders Thursday May 22, 2014 At 9:00 AM Eastern; Webcast Will Be Available 5/15/2014 9:42:22 AM
Emergent BioSolutions (EBS) Reports First Quarter 2014 Financial Results 5/9/2014 7:25:30 AM
Emergent BioSolutions (EBS) To Release First Quarter 2014 Financial Results And Conduct A Conference Call On May 8, 2014 4/23/2014 7:14:13 AM
Emergent BioSolutions (EBS) And FDA Finalize Comparability Protocols Enabling Manufacturing Of Biothrax Consistency Lots In Building 55 4/22/2014 8:05:22 AM
Emergent BioSolutions (EBS) Receives Orphan Drug Designation For BioThrax For Post-Exposure Prophylaxis Of Anthrax Disease 4/21/2014 9:40:23 AM
Emergent BioSolutions (EBS) To Participate In May 2014 Investor Conferences 4/17/2014 6:55:33 AM
Emergent BioSolutions (EBS) Successfully Completes Pivotal Clinical Study To Support Expanded Indication For BioThrax 4/16/2014 9:08:41 AM
Emergent BioSolutions (EBS) Reports Financial Results For 2013 3/7/2014 6:45:43 AM
Biodel Inc. (BIOD) Announces Commercial Manufacturing Agreement With Emergent BioSolutions (EBS) For Glucagon Rescue Product 3/6/2014 9:31:11 AM